{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T20:08:08Z","timestamp":1789502888740,"version":"build-2803163510"},"reference-count":36,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Sara and Alex Othon Fund","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]},{"name":"NIH\/NIAMS","award":["K23-AR-075112"],"award-info":[{"award-number":["K23-AR-075112"]}]},{"name":"NIH\/NIAMS","award":["K24 AR080217"],"award-info":[{"award-number":["K24 AR080217"]}]},{"name":"NIH\/NIAMS","award":["P30 AR070254"],"award-info":[{"award-number":["P30 AR070254"]}]},{"name":"NIH\/NIAMS","award":["P30 AR072582"],"award-info":[{"award-number":["P30 AR072582"]}]},{"name":"NIH\/NIAMS","award":["R01 AR073208"],"award-info":[{"award-number":["R01 AR073208"]}]},{"name":"NIH\/NIAMS","award":["T32 AR048522-19"],"award-info":[{"award-number":["T32 AR048522-19"]}]},{"DOI":"10.13039\/100015629","name":"Jerome L. Greene Foundation","doi-asserted-by":"publisher","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/100015629","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Johns Hopkins inHealth initiative","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]},{"name":"Martha McCrory Professorship","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]},{"DOI":"10.13039\/100001845","name":"Scleroderma Research Foundation","doi-asserted-by":"publisher","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/100001845","id-type":"DOI","asserted-by":"publisher"}]},{"name":"NIH\/NHLBI","award":["R01-HL-164758"],"award-info":[{"award-number":["R01-HL-164758"]}]},{"DOI":"10.13039\/100029250","name":"Donald B. and Dorothy L. Stabler Foundation","doi-asserted-by":"publisher","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/100029250","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Chresanthe Staurulakis Memorial Discovery Fund","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]},{"DOI":"10.13039\/100000005","name":"Department of Defense","doi-asserted-by":"crossref","award":["W81XWH2210163"],"award-info":[{"award-number":["W81XWH2210163"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Bechtle Precision Medicine Fund in Scleroderma","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1136\/ard-2023-225458","type":"journal-article","created":{"date-parts":[[2024,7,17]],"date-time":"2024-07-17T17:15:35Z","timestamp":1721236535000},"page":"1513-1521","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Racial variability in immune responses only partially explains differential systemic sclerosis disease severity"],"prefix":"10.1016","volume":"83","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8384-7634","authenticated-orcid":false,"given":"Kamini E","family":"Kuchinad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji Soo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrianne","family":"Woods","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gwen","family":"Leatherman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Gutierrez-Alamillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maureen D","family":"Mayes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2765-0922","authenticated-orcid":false,"given":"Robyn","family":"Domsic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9433-6634","authenticated-orcid":false,"given":"Paula S","family":"Ramos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2038-3278","authenticated-orcid":false,"given":"Richard M","family":"Silver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Varga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lesley Ann","family":"Saketkoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne","family":"Kafaja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria K","family":"Shanmugan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorinda","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5560-6390","authenticated-orcid":false,"given":"Elana J","family":"Bernstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pravitt","family":"Gourh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Boin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7188-4550","authenticated-orcid":false,"given":"Daniel L","family":"Kastner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott L","family":"Zeger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4172-1539","authenticated-orcid":false,"given":"Livia","family":"Casciola-Rosen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fredrick M","family":"Wigley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1139-2009","authenticated-orcid":false,"given":"Ami A","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1136\/ard-2023-225458_bib1","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1002\/art.38098","article-title":"Classification criteria for systemic sclerosis: an American college of rheumatology\/European League against rheumatism collaborative initiative","volume":"65","author":"van den Hoogen","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard-2023-225458_bib2","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/art.1780230510","article-title":"Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American rheumatism Association diagnostic and therapeutic criteria committee","volume":"23","author":"Masi","year":"1980","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard-2023-225458_bib3","doi-asserted-by":"crossref","first-page":"e8980","DOI":"10.1097\/MD.0000000000008980","article-title":"Clinical and serological features of systemic sclerosis in a multicenter African American cohort: analysis of the genome research in African American scleroderma patients clinical database","volume":"96","author":"Morgan","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"10.1136\/ard-2023-225458_bib4","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/MD.0b013e31829be125","article-title":"Race and association with disease manifestations and mortality in scleroderma: a 20-year experience at the Johns Hopkins scleroderma center and review of the literature","volume":"92","author":"Gelber","year":"2013","journal-title":"Medicine (Baltimore)"},{"key":"10.1136\/ard-2023-225458_bib5","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1002\/art.1780400421","article-title":"Racial differences in scleroderma among women in Michigan","volume":"40","author":"Laing","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard-2023-225458_bib6","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1378\/chest.114.3.801","article-title":"African-American race and antibodies to topoisomerase I are associated with increased severity of scleroderma lung disease","volume":"114","author":"Greidinger","year":"1998","journal-title":"Chest"},{"key":"10.1136\/ard-2023-225458_bib7","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1002\/art.11073","article-title":"Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large US population","volume":"48","author":"Mayes","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard-2023-225458_bib8","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1002\/art.24734","article-title":"Clinical and genetic factors predictive of mortality in early systemic sclerosis","volume":"61","author":"Assassi","year":"2009","journal-title":"Arthritis Care Res"},{"key":"10.1136\/ard-2023-225458_bib9","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.3899\/jrheum.110071","article-title":"Anti-Fibrillarin antibody in African American patients with systemic sclerosis: immunogenetics, clinical features, and survival analysis","volume":"38","author":"Sharif","year":"2011","journal-title":"J Rheumatol"},{"key":"10.1136\/ard-2023-225458_bib10","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1007\/s10067-011-1751-0","article-title":"Gender and ethnicity differences in the prevalence of scleroderma-related autoantibodies","volume":"30","author":"Krzyszczak","year":"2011","journal-title":"Clin Rheumatol"},{"key":"10.1136\/ard-2023-225458_bib11","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.semarthrit.2005.03.005","article-title":"Autoantibodies in systemic sclerosis","volume":"35","author":"Steen","year":"2005","journal-title":"Semin Arthritis Rheum"},{"key":"10.1136\/ard-2023-225458_bib12","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1002\/acr.23861","article-title":"Increased morbidity and mortality of scleroderma in African Americans compared to non-African Americans","volume":"71","author":"Moore","year":"2019","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1136\/ard-2023-225458_bib13","doi-asserted-by":"crossref","first-page":"R50","DOI":"10.1186\/ar3763","article-title":"Clinical significance of antibodies to Ro52\/Trim21 in systemic sclerosis","volume":"14","author":"Hudson","year":"2012","journal-title":"Arthritis Res Ther"},{"key":"10.1136\/ard-2023-225458_bib14","first-page":"S131","article-title":"Monospecific anti-Ro52\/Trim21 antibodies in a tri-nation cohort of 1574 systemic sclerosis subjects: evidence of an association with interstitial lung disease and worse survival","volume":"33","author":"Wodkowski","year":"2015","journal-title":"Clin Exp Rheumatol"},{"key":"10.1136\/ard-2023-225458_bib15","doi-asserted-by":"crossref","first-page":"2986","DOI":"10.1002\/art.34482","article-title":"A clinical and serologic comparison of African American and caucasian patients with systemic sclerosis","volume":"64","author":"Steen","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard-2023-225458_bib16","doi-asserted-by":"crossref","DOI":"10.3899\/jrheum.091048","article-title":"Association of RNA polymerase III antibodies with scleroderma renal crisis","volume":"37","author":"Nguyen","year":"2010","journal-title":"J Rheumatol"},{"key":"10.1136\/ard-2023-225458_bib17","unstructured":"R Core Team,. R: A language and environment for statistical computing R foundation for statistical. R Foundation for Statistical Computing. 2020, Available: https:\/\/www.r-project.org\/."},{"key":"10.1136\/ard-2023-225458_bib18","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1093\/rheumatology\/keab395","article-title":"Autoantibody predictors of gastrointestinal symptoms in systemic sclerosis","volume":"61","author":"Ahmed","year":"2022","journal-title":"Rheumatology (Oxford)"},{"key":"10.1136\/ard-2023-225458_bib19","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/j.1756-185X.2011.01688.x","article-title":"South Australian scleroderma register: autoantibodies as predictive biomarkers of phenotype and outcome","volume":"15","author":"Graf","year":"2012","journal-title":"Int J Rheum Dis"},{"key":"10.1136\/ard-2023-225458_bib20","doi-asserted-by":"crossref","first-page":"272","DOI":"10.3109\/s10165-011-0515-7","article-title":"Clinical features of 405 Japanese patients with systemic sclerosis","volume":"22","author":"Hashimoto","year":"2012","journal-title":"Mod Rheumatol"},{"key":"10.1136\/ard-2023-225458_bib21","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1002\/art.39432","article-title":"Characteristics and survival of anti-U1 RNP antibody-positive patients with connective tissue disease-associated pulmonary arterial hypertension","volume":"68","author":"Sobanski","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"10.1136\/ard-2023-225458_bib22","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1080\/03009742.2021.1887927","article-title":"Anti-Ro52\/Trim21 is independently associated with pulmonary arterial hypertension and mortality in a cohort of systemic sclerosis patients","volume":"50","author":"Lee","year":"2021","journal-title":"Scand J Rheumatol"},{"key":"10.1136\/ard-2023-225458_bib23","first-page":"1600","article-title":"Anti-th\/to-positivity in a cohort of patients with idiopathic pulmonary fibrosis","volume":"33","author":"Fischer","year":"2006","journal-title":"J Rheumatol"},{"key":"10.1136\/ard-2023-225458_bib24","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/art.41493","article-title":"Cancer in systemic sclerosis: analysis of antibodies against components of the th\/to complex","volume":"73","author":"Mecoli","year":"2021","journal-title":"Arthritis Rheumatol"},{"key":"10.1136\/ard-2023-225458_bib25","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s40674-016-0050-y","article-title":"Autoantibodies and their role in scleroderma clinical care","volume":"2","author":"Domsic","year":"2016","journal-title":"Curr Treat Options in Rheum"},{"key":"10.1136\/ard-2023-225458_bib26","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1002\/art.42152","article-title":"Development of pulmonary hypertension in over one-third of patients with th\/to antibody\u2013positive scleroderma in long-term follow-up","volume":"74","author":"Suresh","year":"2022","journal-title":"Arthritis Rheumatol"},{"key":"10.1136\/ard-2023-225458_bib27","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1002\/art.38428","article-title":"Clinical and serologic correlates of anti-PM\/Scl antibodies in systemic sclerosis: a multicenter study of 763 patients","volume":"66","author":"D'Aoust","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"10.1136\/ard-2023-225458_bib28","doi-asserted-by":"crossref","first-page":"e2068","DOI":"10.1212\/WNL.0000000000005638","article-title":"Muscular and extramuscular clinical features of patients with anti-PM\/Scl autoantibodies","volume":"90","author":"De Lorenzo","year":"2018","journal-title":"Neurology"},{"key":"10.1136\/ard-2023-225458_bib29","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1093\/rheumatology\/keac508","article-title":"Anti-PM-Scl antibodies-positive patients encompass three different groups with distinct prognoses","volume":"62","author":"Breillat","year":"2023","journal-title":"Rheumatology (Oxford)"},{"key":"10.1136\/ard-2023-225458_bib30","doi-asserted-by":"crossref","first-page":"3636","DOI":"10.1093\/rheumatology\/keac682","article-title":"Cumulative disease damage and anti-PM\/Scl antibodies are associated with a heavy burden of calcinosis in systemic sclerosis","volume":"62","author":"Richardson","year":"2023","journal-title":"Rheumatology"},{"key":"10.1136\/ard-2023-225458_bib31","doi-asserted-by":"crossref","first-page":"5028","DOI":"10.1093\/rheumatology\/keab152","article-title":"The clinical phenotype of systemic sclerosis patients with anti-PM\/Scl antibodies: results from the EUSTAR cohort","volume":"60","author":"Lazzaroni","year":"2021","journal-title":"Rheumatology (Oxford)"},{"key":"10.1136\/ard-2023-225458_bib32","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1002\/art.24409","article-title":"Anti-U3 RNP autoantibodies in systemic sclerosis","volume":"60","author":"Aggarwal","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard-2023-225458_bib33","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1002\/art.1780350114","article-title":"Autoantibody to U3 nucleolar ribonucleoprotein (Fibrillarin) in patients with systemic sclerosis","volume":"35","author":"Okano","year":"1992","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard-2023-225458_bib34","doi-asserted-by":"crossref","first-page":"11212","DOI":"10.1038\/s41598-022-15062-4","article-title":"Combinations of scleroderma hallmark autoantibodies associate with distinct clinical phenotypes","volume":"12","author":"Clark","year":"2022","journal-title":"Sci Rep"},{"key":"10.1136\/ard-2023-225458_bib35","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/acr2.11206","article-title":"Racial disparities in systemic sclerosis: short- and long-term outcomes among African American participants of SLS I and II","volume":"3","author":"Volkmann","year":"2021","journal-title":"ACR Open Rheumatol"},{"key":"10.1136\/ard-2023-225458_bib36","first-page":"1238","article-title":"Patterns of hospital admissions and emergency room visits among patients with scleroderma in South Carolina, USA","volume":"30","author":"Nietert","year":"2003","journal-title":"J Rheumatol"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724665441?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724665441?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ard-2023-225458","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,4]],"date-time":"2025-01-04T08:17:37Z","timestamp":1735978657000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724665441"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":36,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S0003496724665441"],"URL":"https:\/\/doi.org\/10.1136\/ard-2023-225458","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Racial variability in immune responses only partially explains differential systemic sclerosis disease severity","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ard-2023-225458","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2024 \u00a9 Author(s) (or their employer(s)) 2024. No commercial re-use. See rights and permissions. Published by Elsevier Inc on behalf of EULAR. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}